Neuralink, the brain-chip company founded by Elon Musk, has announced that it has obtained approval from the US Food and Drugs Administration (FDA) to commence its initial human tests.

The objective of Neuralink’s implant technology is to restore vision and mobility by establishing a connection between the human brain and computers.

While the company does not currently have immediate plans to recruit participants, this approval marks a significant milestone after a previous unsuccessful attempt to gain FDA approval due to safety concerns.

Neuralink aims to utilize microchips to address conditions like paralysis and blindness, enabling disabled individuals to utilize computers and mobile devices.

These microchips, which have been tested on monkeys, interpret brain signals and transmit information to external devices via Bluetooth.

ALSO READ: United States imposes fresh sanctions on Russia and Iran over wrongful detention of Americans

Experts caution that extensive testing is necessary to overcome technical and ethical challenges before Neuralink’s brain implants can be widely accessible.

Elon Musk has previously suggested that this technology could alleviate concerns about AI displacing humans.

Neuralink expressed gratitude to the FDA for their collaboration and promised more details about their upcoming trials.

The company emphasizes safety, accessibility, and reliability as key priorities in their engineering process.

This FDA approval comes shortly after Swiss researchers achieved a similar breakthrough with brain implants, enabling a paralyzed man to walk by simply thinking about it